News Analysis

Most Recent

Bacteria rapidly develop resistance to new antibiotic

By | April 20, 2001

can quickly become resistant to linezolid during extended treatment.

0 Comments

After the (draft) sequence

By | April 18, 2001

Now that the dust has settled after publication of the human genome sequence, Sydney Brenner assesses the first draft.

0 Comments

but protection possible in four days

By | March 30, 2001

As the UK government considers a limited foot-and-mouth disease vaccination programme, there's evidence that the current vaccines aren't perfect but high doses could help stop transmission.

0 Comments

NHS pays damages to hepatitis victims

By | March 27, 2001

The National Health Service faces a substantial compensation bill from patients who contracted hepatitis C from infected blood supplies.

0 Comments

The power of the electronic thesis

By | March 27, 2001

Delegates at a conference last week called for more academic institutions to make theses and dissertations available online.

0 Comments

Will foot-and-mouth disease vaccines work?

By | March 27, 2001

The UK could be preparing to vaccinate farm animals against foot-and-mouth disease. But will the vaccines be effective against the current strain?

0 Comments

The ins and outs of data

By | January 8, 2001

Germany's Max Planck Society is setting up a Centre for Information Management that aims to give its researchers greater power over the way their work is published.

0 Comments

Age-related macular degeneration (AMD) is the leading cause of blindness in individuals over 55 years of age in the developed world. AMD affects about 11 million Americans, 5 million of whom have become legally blind because of it. Stargardt's macular degeneration (STGD3) is an early-onset form of AMD that affects about 30,000 children and young adults in the United States. Researchers reported in this week's Nature Genetics that they have identified a gene linked to AMD and predicted the discov

0 Comments

Have the will, have the data

By | January 5, 2001

Referees on strike, and a new "template" for academic electronic publishing; sound familiar? This time it's economists on the warpath, and they have figures to shoot with.

0 Comments

Stop in the name of ethics

By | January 4, 2001

A French research team is criticised for allowing a clinical trial to continue even though preliminary results suggested the drug therapies were ineffective.

0 Comments

Popular Now

  1. Optimism for Key Deer After Hurricane Irma
  2. Do Microbes Trigger Alzheimer’s Disease?
  3. Decoding the Tripping Brain
  4. Tattoo Ink Nanoparticles Persist in Lymph Nodes
    The Nutshell Tattoo Ink Nanoparticles Persist in Lymph Nodes

    Analysis of the bodies of deceased individuals can’t determine what effect these tattoo remnants have on lymph function, but researchers suggest dirty needles aren’t the only risk of the age-old practice.

AAAS